Precision Antibody-Based Therapeutics for Complement Regulation
Time: 3:00 pm
day: Track A - Day 1 PM
Details:
- Targeting critical components of the complement pathway can impact diseases that are initiated or
exacerbated by complement dysregulation - Antibody based therapeutics can be used to precisely target and potently inhibit complement activation
- Visterra has developed novel antibodies for targeting complement activation
